Market Overview:
The global knee osteoarthritis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of knee osteoarthritis, rising geriatric population, and technological advancements in the field of knee osteoarthritis treatment. The non-surgical treatment segment is expected to dominate the global knee osteoarthritis treatment market during the forecast period. This can be attributed to factors such as lower cost and less invasive nature of these treatments as compared to surgical treatments. However, surgical treatments are expected to witness higher growth during the forecast period owing to their ability to provide long-term relief from pain and improve joint function.
Product Definition:
Osteoarthritis is the most common type of arthritis, affecting millions of people in the United States. It occurs when the protective cartilage on the ends of bones wears down, causing pain, stiffness and swelling. Treatment options include over-the-counter and prescription medications, injections, braces or supports, physical therapy and surgery.
Non-surgical Treatment:
Non-surgical treatment is a growing sector in the knee osteoarthritis (OA) treatment market. The factors that propel its growth include increasing geriatric population, rising prevalence of knee OA and technological advancements such as minimally invasive surgeries.
According to the International Journal of Clinical Rheumatology, up to 50% of people with knee osteoarthritis are unable to get relief from conventional medications used for pain management due to adverse effects or lack of efficacy.
Surgical Treatment:
Surgical treatment and it's usage in Knee Osteoarthritis (KA) treatment market is analyzed by considering the number of procedures performed, their outcomes and complications, reimbursement scenario etc. The global knee osteoarthritis (KA) treatments market was valued at USD 16.1 billion in 2016 which is anticipated to grow at a CAGR of XX% over the forecast period.
Osteoarthritis affects around 30 million people in U.
Application Insights:
The others segment held the largest share of the global knee osteoarthritis treatment market in 2017. This segment includes physical therapy, massage, traction and bracing. The others segment dominated the market by application as there are many effective treatments that can be used without surgery. Non-surgical treatments such as physical therapy and surgical procedures dominate this category due to their effectiveness in treating knee osteoarthritis pain without any significant side effects or complications associated with them.
Knee replacement is one of the most common surgeries performed for patients suffering from moderate to severe arthritis of the joint overuse injuries or trauma causing wear & tear on cartilage surfaces leading to bone death & tissue loss around joints which results in pain.
Regional Analysis:
North America dominated the global knee osteoarthritis treatment market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of advanced medical products and devices, higher per capita health expenditure, and rising prevalence of osteoarthritis. In addition, high consumer awareness levels coupled with a strong preference for minimally invasive surgeries are expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure in countries such as India and China along with increasing investments by manufacturers in this region. Furthermore, growing patient awareness levels regarding available treatments options will also support regional market growth during the estimated time frame. The Middle East & Africa region is projected to exhibit significant CAGR over the next eight years due its large geriatric population base that requires cost-effective treatment options for various chronic conditions associated with aging; such as osteoarthritis (OA).
Growth Factors:
- Increasing aging population: The global population is aging at an alarming rate, and this is expected to drive the demand for knee osteoarthritis treatment products and services.
- Rising awareness about knee osteoarthritis: There is a growing awareness among people about the symptoms and treatment options for knee osteoarthritis. This is likely to boost the demand for knee osteoarthritis treatments in the coming years.
- Growing prevalence of obesity: Obesity has been identified as one of the major risk factors for developing knee osteoarthritis. As obesity rates continue to rise around the world, so will the number of people affected by this condition, driving demand for effective treatments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Knee Osteoarthritis Treatment Market Research Report
By Type
Non-surgical Treatment, Surgical Treatment
By Application
Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
By Companies
Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Knee Osteoarthritis Treatment Market Report Segments:
The global Knee Osteoarthritis Treatment market is segmented on the basis of:
Types
Non-surgical Treatment, Surgical Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bioventus
- AVM Biotechnology
- Anika Therapeutics
- Flexion Therapeutics
- OrthoTrophix
- Sanofi
- Horizon Therapeutics
- Johnson and Johnson
- GlaxoSmithKline
- Bayer
- Abbott
- Pfizer
- Eli Lilly
Highlights of The Knee Osteoarthritis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-surgical Treatment
- Surgical Treatment
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Knee Osteoarthritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Knee osteoarthritis treatment typically includes pain relief medications, physical therapy, and surgery.
Some of the major players in the knee osteoarthritis treatment market are Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly.
The knee osteoarthritis treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Knee Osteoarthritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Knee Osteoarthritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Knee Osteoarthritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Knee Osteoarthritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Knee Osteoarthritis Treatment Market Size & Forecast, 2018-2028
4.5.1 Knee Osteoarthritis Treatment Market Size and Y-o-Y Growth
4.5.2 Knee Osteoarthritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Knee Osteoarthritis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Knee Osteoarthritis Treatment Market Size Forecast by Type
5.2.1 Non-surgical Treatment
5.2.2 Surgical Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Knee Osteoarthritis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Knee Osteoarthritis Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Specialty Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Knee Osteoarthritis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Knee Osteoarthritis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Knee Osteoarthritis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Knee Osteoarthritis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Knee Osteoarthritis Treatment Market Size Forecast by Type
9.6.1 Non-surgical Treatment
9.6.2 Surgical Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Knee Osteoarthritis Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Specialty Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Knee Osteoarthritis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Knee Osteoarthritis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Knee Osteoarthritis Treatment Market Size Forecast by Type
10.6.1 Non-surgical Treatment
10.6.2 Surgical Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Knee Osteoarthritis Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Specialty Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Knee Osteoarthritis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Knee Osteoarthritis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Knee Osteoarthritis Treatment Market Size Forecast by Type
11.6.1 Non-surgical Treatment
11.6.2 Surgical Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Knee Osteoarthritis Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Specialty Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Knee Osteoarthritis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Knee Osteoarthritis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Knee Osteoarthritis Treatment Market Size Forecast by Type
12.6.1 Non-surgical Treatment
12.6.2 Surgical Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Knee Osteoarthritis Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Specialty Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Knee Osteoarthritis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Knee Osteoarthritis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Knee Osteoarthritis Treatment Market Size Forecast by Type
13.6.1 Non-surgical Treatment
13.6.2 Surgical Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Knee Osteoarthritis Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Specialty Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Knee Osteoarthritis Treatment Market: Competitive Dashboard
14.2 Global Knee Osteoarthritis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bioventus
14.3.2 AVM Biotechnology
14.3.3 Anika Therapeutics
14.3.4 Flexion Therapeutics
14.3.5 OrthoTrophix
14.3.6 Sanofi
14.3.7 Horizon Therapeutics
14.3.8 Johnson and Johnson
14.3.9 GlaxoSmithKline
14.3.10 Bayer
14.3.11 Abbott
14.3.12 Pfizer
14.3.13 Eli Lilly
